Partial Nephrectomy (Robotic, Laparoscopic, or Open)
Laparoscopic Partial Nephrectomy
A laparoscopic partial nephrectomy is performed under general anaesthetic, using 2 different approaches.
In the transperitoneal approach, the abdomen is insufflated with carbon dioxide and three or four small abdominal incisions are made.
In the retroperitoneal approach, a small incision is made in the back and a dissecting balloon is inserted to create a retroperitoneal space. After insufflation with carbon dioxide, two or three additional small incisions are made in the back. The renal vessels are identified and either isolated using vessel loops or clamped and the kidney is mobilised to allow exposure of the lesion. A laparoscopic ultrasound probe may be used to determine the line of incision and depth of tumour involvement. Bleeding vessels are sealed or ligated with sutures and the renal capsule is then closed. The specimen is enclosed in a bag and retrieved through an expanded port.
Robotic da Vinci for Kidney Cancer
The three forms of surgical treatment are:
Kidney surgery is traditionally performed using an open approach, which requires a large abdominal incision. Another approach, conventional laparoscopy, is less invasive, but limits the doctor’s dexterity, visualization and control, compared to open surgery.
da Vinci for Kidney Cancer
If your doctor recommends surgery for kidney cancer, you may be a candidate for a new, minimally invasive approach – da Vinci Partial Nephrectomy or Nephrectomy.
da Vinci Surgery uses state-of-the-art technology to help your doctor perform a more precise operation than conventional instrumentation allows. It offers numerous potential benefits over a conventional open surgery, including:
da Vinci Surgery for kidney cancer incorporates the best techniques of open surgery and applies them to a robotic-assisted, minimally invasive approach.
The precision and dexterity afforded by the da Vinci Surgical System’s advanced instrumentation facilitates a minimally invasive approach for treating kidney cancer.
Education / Resources
- American Cancer Society
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- National Comprehensive Cancer Network (NCCN)
Prostate Cancer Therapeutics
- Xtandi – Enzalutamide
- Vantas – Histrelin Acetate
- LupronDepot – Leuprolide Acetate for Depot Suspension
- Eligard – Leuprolide Acetate for Injectable Suspension
- Firmagon – Degarelix for Injection
- Xgeva – Denosumab Injection
- Prolia – Denosumab
- Zytiga – Abiratirone
Bladder Cancer Therapeutics